Kelyniam Global, Inc. has added two senior Executives to its team in the first quarter. Terrance Kurtenbach, a retired 25-year partner at Deloitte has joined the company as Chief Financial Officer. Mr. Kurtenbach has extensive life sciences company experience and was previously the head of Deloitte's Global Life Sciences tax practice, assisting Medical Device, Bio-tech and Pharmaceutical life sciences companies across the world.

In addition, Mr. Kurtenbach has been nominated to the Board of Directors. Mr. James Barrow Esq. joined the company as Director of Quality and Regulatory in March and will also serve as General Counsel.

Mr. Barrow has more than 35 years of experience in the Medical Device, Pharmaceutical, and Diagnostics industries, holding leadership roles in Quality, Regulatory and Clinical Development.